期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | TRANSFUSION MEDICINE LetPub Score 5.4
50 ratings
Rate
Reputation 6.3 Influence 3.8 Speed 9.4 | ||||||||||||||||
期刊簡稱 | TRANSFUSION MED | ||||||||||||||||
ISSN | 0958-7578 | ||||||||||||||||
E-ISSN | 1365-3148 | ||||||||||||||||
h-index | 55 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 6.70%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-3148 | ||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/transmed | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1991 | ||||||||||||||||
每年文章數 | 46每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 18.93% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0958-7578%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[TRANSFUSION MEDICINE] 的評論 | 撰寫評論 |
作者: 御阪永贺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-25 20:52:13 評論於 How many co-first authors and co-corresponding authors are allowed in the magazine TRANSFUSION?(0) 讚! | 御阪永贺 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:17:10 評論於 It is still necessary for us to clearly explain the limitations of the research in the paper and to discuss the impact of these limitations on the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the study. Typically, discussing the limitations of the study in the discussion section makes the article more credible. Thinking about how to overcome these limitations in future research will have a good effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:48:17 評論於 We recommend dividing discussions on research limitations into three parts: (1) Identifying research limitations; (2) Detailing explanations of research limitations; and (3) Proposing future research directions or improvement suggestions. By discussing research limitations in this order, you can clearly identify research gaps without compromising the quality and validity of the study(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:59:10 評論於 How to write about limitations in a discussion?(0) 讚! | Darlene Pepys |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:39:26 評論於 Do we need to point out the limitations of the article in the discussion?(0) 讚! | 平原文波 |
作者: 珉林宇达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-15 11:05:11 評論於 Do I need to pay the publication fee in advance?(0) 讚! | 珉林宇达 |
作者: 五郎梓奥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-05 18:47:15 評論於 After one month of submission, I received the review comments, which is considered quite fast. The reviewers' comments are not difficult to address, but the journal refused to provide the opportunity for revision(0) 讚! | 五郎梓奥 |
作者: little forest 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2018-04-05 11:01:22 評論於 Review comments came one month after submission; this is fairly quick. The reviewer's comments were not difficult to address, but the journal did not give me the opportunity to revise the paper. (0) 讚! | little forest |
作者: 大力睿博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-20 19:37:04 評論於 How long does it take to review the manuscript? Posted by hfcj0817 on August 13, 2016 at 23:53:00: Submitted one article today. Manuscript number 177. Acceptance rate is around 25%(0) 讚! | 大力睿博 |
作者: Susie Jenny 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-13 10:42:23 評論於 Submission success rate: 25.0 Experience sharing: I submitted an article today with submission number 177, and the success rate is around 25%(0) 讚! | Susie Jenny |
作者: Nikita 領域: 医药科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-03-23 16:28:32 評論於 The journal is very fast, and it will be returned for less than a month. Because it was used for almost two months, it was used for the second day after the repair!(0) 讚! | Nikita |
作者: 法慧才良 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-03-23 09:44:29 評論於 Review speed: 3.0 Experience sharing: The magazine is very fast, providing feedback in less than a month. Due to the Chinese New Year, it took about two months to make revisions, and the day after the revisions were submitted, the article was accepted!(0) 讚! | 法慧才良 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-03-11 18:03:04 評論於 The review process is very slow. It has been over a month since submission, and the paper is still with the editor(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us